Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396711 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Xeroderma Pigmentosum, Complementation Group C (XPC) (AA 141-251) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 141-251
- Isotype
- IgG
- Antibody clone number
- 6D11
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma.
Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer.
XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.
Figl A, Scherer D, Nagore E, Bermejo JL, Botella-Estrada R, Gast A, Thirumaran RK, Planelles D, Hemminki K, Schadendorf D, Kumar R
Mutation research 2010 Sep 30;702(1):8-16
Mutation research 2010 Sep 30;702(1):8-16
Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population.
Long XD, Ma Y, Zhou YF, Ma AM, Fu GH
Hepatology (Baltimore, Md.) 2010 Oct;52(4):1301-9
Hepatology (Baltimore, Md.) 2010 Oct;52(4):1301-9
Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer.
Palli D, Polidoro S, D'Errico M, Saieva C, Guarrera S, Calcagnile AS, Sera F, Allione A, Gemma S, Zanna I, Filomena A, Testai E, Caini S, Moretti R, Gomez-Miguel MJ, Nesi G, Luzzi I, Ottini L, Masala G, Matullo G, Dogliotti E
Mutagenesis 2010 Nov;25(6):569-75
Mutagenesis 2010 Nov;25(6):569-75
XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
Guillem VM, Cervantes F, Martínez J, Alvarez-Larrán A, Collado M, Camós M, Sureda A, Maffioli M, Marugán I, Hernández-Boluda JC
American journal of hematology 2010 Jul;85(7):482-6
American journal of hematology 2010 Jul;85(7):482-6
XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancer.
Zhu LB, Xu Q, Hong CY, Yue Z, Zhang Y, Ye HN, Yuan Y
Anti-cancer drugs 2010 Aug;21(7):669-73
Anti-cancer drugs 2010 Aug;21(7):669-73
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
